vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and AdvanSix Inc. (ASIX). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $329.5M, roughly 1.1× Andersons, Inc.). Andersons, Inc. runs the higher net margin — 20.5% vs -0.8%, a 21.2% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -2.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-77.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
ANDE vs ASIX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $359.9M |
| Net Profit | $67.4M | $-2.8M |
| Gross Margin | 70.3% | 7.6% |
| Operating Margin | 26.6% | -0.7% |
| Net Margin | 20.5% | -0.8% |
| Revenue YoY | -2.4% | 9.4% |
| Net Profit YoY | 49.6% | -892.9% |
| EPS (diluted) | — | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $359.9M | ||
| Q3 25 | $295.8M | $374.5M | ||
| Q2 25 | $535.0M | $410.0M | ||
| Q1 25 | $370.8M | $377.8M | ||
| Q4 24 | $337.5M | $329.1M | ||
| Q3 24 | $231.9M | $398.2M | ||
| Q2 24 | $492.5M | $453.5M | ||
| Q1 24 | $341.4M | $336.8M |
| Q4 25 | $67.4M | $-2.8M | ||
| Q3 25 | $20.1M | $-2.6M | ||
| Q2 25 | $7.9M | $31.4M | ||
| Q1 25 | $284.0K | $23.3M | ||
| Q4 24 | $45.1M | $352.0K | ||
| Q3 24 | $27.4M | $22.3M | ||
| Q2 24 | $36.0M | $38.9M | ||
| Q1 24 | $5.6M | $-17.4M |
| Q4 25 | 70.3% | 7.6% | ||
| Q3 25 | 57.8% | 6.8% | ||
| Q2 25 | 29.6% | 14.3% | ||
| Q1 25 | 41.2% | 14.2% | ||
| Q4 24 | 63.1% | 3.4% | ||
| Q3 24 | 76.4% | 14.4% | ||
| Q2 24 | 35.6% | 17.9% | ||
| Q1 24 | 37.6% | 0.9% |
| Q4 25 | 26.6% | -0.7% | ||
| Q3 25 | 8.7% | -0.9% | ||
| Q2 25 | 4.6% | 7.7% | ||
| Q1 25 | 0.9% | 7.7% | ||
| Q4 24 | 19.9% | -3.9% | ||
| Q3 24 | 26.8% | 7.5% | ||
| Q2 24 | 11.6% | 11.5% | ||
| Q1 24 | 4.1% | -7.0% |
| Q4 25 | 20.5% | -0.8% | ||
| Q3 25 | 6.8% | -0.7% | ||
| Q2 25 | 1.5% | 7.7% | ||
| Q1 25 | 0.1% | 6.2% | ||
| Q4 24 | 13.4% | 0.1% | ||
| Q3 24 | 11.8% | 5.6% | ||
| Q2 24 | 7.3% | 8.6% | ||
| Q1 24 | 1.6% | -5.2% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $0.59 | $-0.10 | ||
| Q2 25 | $0.23 | $1.15 | ||
| Q1 25 | $0.01 | $0.86 | ||
| Q4 24 | $1.31 | $0.02 | ||
| Q3 24 | $0.80 | $0.82 | ||
| Q2 24 | $1.05 | $1.43 | ||
| Q1 24 | $0.16 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $19.8M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $815.2M |
| Total Assets | $3.7B | $1.7B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $19.8M | ||
| Q3 25 | — | $23.7M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | $561.8M | $19.6M | ||
| Q3 24 | — | $17.3M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $20.6M |
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $815.2M | ||
| Q3 25 | $1.2B | $818.2M | ||
| Q2 25 | $1.4B | $823.7M | ||
| Q1 25 | $1.4B | $794.4M | ||
| Q4 24 | $1.4B | $774.6M | ||
| Q3 24 | $1.3B | $766.4M | ||
| Q2 24 | $1.3B | $746.6M | ||
| Q1 24 | $1.3B | $713.2M |
| Q4 25 | $3.7B | $1.7B | ||
| Q3 25 | $3.3B | $1.7B | ||
| Q2 25 | $3.4B | $1.6B | ||
| Q1 25 | $3.8B | $1.6B | ||
| Q4 24 | $4.1B | $1.6B | ||
| Q3 24 | $3.4B | $1.5B | ||
| Q2 24 | $3.3B | $1.5B | ||
| Q1 24 | $3.3B | $1.5B |
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $63.7M |
| Free Cash FlowOCF − Capex | $-77.1M | $36.1M |
| FCF MarginFCF / Revenue | -23.4% | 10.0% |
| Capex IntensityCapex / Revenue | 21.5% | 7.7% |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $6.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $63.7M | ||
| Q3 25 | $233.9M | $26.6M | ||
| Q2 25 | $299.3M | $21.1M | ||
| Q1 25 | $-350.0M | $11.4M | ||
| Q4 24 | $268.8M | $64.2M | ||
| Q3 24 | $-2.1M | $57.3M | ||
| Q2 24 | $304.4M | $50.2M | ||
| Q1 24 | $-239.6M | $-36.2M |
| Q4 25 | $-77.1M | $36.1M | ||
| Q3 25 | $167.0M | $66.0K | ||
| Q2 25 | $250.5M | $-7.2M | ||
| Q1 25 | $-396.6M | $-22.6M | ||
| Q4 24 | $212.9M | $29.8M | ||
| Q3 24 | $-40.0M | $26.8M | ||
| Q2 24 | $275.8M | $16.7M | ||
| Q1 24 | $-266.4M | $-71.6M |
| Q4 25 | -23.4% | 10.0% | ||
| Q3 25 | 56.5% | 0.0% | ||
| Q2 25 | 46.8% | -1.7% | ||
| Q1 25 | -106.9% | -6.0% | ||
| Q4 24 | 63.1% | 9.1% | ||
| Q3 24 | -17.2% | 6.7% | ||
| Q2 24 | 56.0% | 3.7% | ||
| Q1 24 | -78.0% | -21.3% |
| Q4 25 | 21.5% | 7.7% | ||
| Q3 25 | 22.6% | 7.1% | ||
| Q2 25 | 9.1% | 6.9% | ||
| Q1 25 | 12.6% | 9.0% | ||
| Q4 24 | 16.6% | 10.4% | ||
| Q3 24 | 16.3% | 7.7% | ||
| Q2 24 | 5.8% | 7.4% | ||
| Q1 24 | 7.8% | 10.5% |
| Q4 25 | -0.09× | — | ||
| Q3 25 | 11.61× | — | ||
| Q2 25 | 38.10× | 0.67× | ||
| Q1 25 | -1232.46× | 0.49× | ||
| Q4 24 | 5.96× | 182.29× | ||
| Q3 24 | -0.08× | 2.57× | ||
| Q2 24 | 8.46× | 1.29× | ||
| Q1 24 | -42.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
